How to Choose an Epidemiologic Study Design (NURS 8310 Week 4 Framework)

Reading Time: 10 minutes

How to Choose an Epidemiologic Study Design (NURS 8310 Week 4 Framework)

The right epidemiologic study design depends on three things: whether the exposure can be ethically manipulated, how rare the outcome is, and how long the latency runs between exposure and outcome. For most population health topics covered in NURS 8310 Week 4 — including smoking and lung cancer, obesity and heart disease, or hormone replacement therapy and breast cancer — these three questions narrow the field from five possible designs down to one defensible choice. This guide walks through that decision process step by step, so you can apply it to whichever risk factor–outcome pairing you select, rather than memorizing one example.

Most students lose points on this assignment not because they picked the “wrong” design, but because they can’t explain why it fits better than the alternatives. That explanation is what this framework is built to produce.

Related: NURS 8310 Week 2: Strengths and Limitations of Secondary Data Sources — Guide and Example

The Assignment: NURS 8310 Week 4

In a 3- to 4-page paper, not including title page and references, address the following:

• Briefly identify the population health topic (association between a risk factor and a health outcome) you selected. Present a research question based on this topic that you would like to answer in a proposed study. (Consult the Walden “Developing Research” resource for guidance on crafting a research question.)
• Explain the epidemiologic study design that would be most appropriate to assess and address your population health problem.
• Summarize the data collection activities you would use (i.e., how you would collect data—online survey, paper/pen, mailing, etc.).
• Explain any specific methodologic strategies you would use. For example, if you were conducting a case-control study, how would you select your cases and controls?
• Consider the methods you would use to make these selections. What are the strengths and limitations of your selected approach?
• Explain ethical considerations pertaining to your study.

What Does the NURS 8310 Week 4 Assignment Actually Ask For?

This assignment asks DNP students to select a population health association of their own choosing, then build a short proposal around it. In broad terms, the task involves:

• Identifying a relationship between a risk factor and a health outcome that genuinely interests you, drawing on course examples or your own area of practice if you prefer
• Writing a clear research question framed around that relationship
• Selecting and justifying one observational or experimental study design as the best fit for investigating it
• Describing how you would realistically gather data for the study
• Explaining the specific methodological choices that design requires (for example, how you’d define and select cases and controls if you went with a case-control approach)
• Weighing the strengths and limitations of your chosen approach against the alternatives
• Addressing the ethical issues your proposed study would raise

It’s typically scoped as a short paper, a handful of pages excluding the title page and references, written in standard academic format. The framework below walks through each of those pieces in the order they usually need to be reasoned through, not necessarily the order they’re listed in the syllabus.

What Makes a Strong Risk Factor–Outcome Pairing?

A strong pairing has a plausible mechanism, an existing evidence base, and is ethically studyable. Before you can choose a study design, you need an association specific enough to support one clear research question.

Curley’s Table 2.2 is a useful starting point if you’re working from the Walden course text (Curley et al., 2025), but the table only lists candidates — it doesn’t tell you which one will produce a strong paper. Look for pairings where:

• A biological or social mechanism connects the exposure to the outcome (not just a statistical correlation you’ve seen referenced somewhere)
• Peer-reviewed literature already exists, giving you something to compare your proposed design against
• The exposure is one you could realistically study without causing harm

Common student mistake: picking something too broad. “Diet and disease” isn’t a pairing — it’s a research area. “Ultra-processed food consumption and type 2 diabetes incidence in adults” is a pairing you can build a research question around.

How Do You Turn a Pairing Into a Research Question?

A well-formed research question names the population, the exposure, the comparison group, and the outcome — all four, explicitly. This is the PICO/PECO structure (Population, Exposure, Comparison, Outcome), and it’s the single biggest predictor of whether the rest of your paper holds together.

Compare these two versions of the same idea:

• Vague: “Does smoking cause lung cancer?”
• Well-formed: “Among adults aged 40–65, is current daily smoking associated with higher incidence of lung cancer compared to never-smokers, over a 10-year period?”

The second version already tells you what kind of study design you need — a defined population, a measurable exposure, a comparison group, and a time horizon. Walden’s “Developing Research” resource walks through this structure in more depth, and it’s worth reviewing alongside this framework rather than instead of it.

How Do You Choose Between Observational and Experimental Designs?

The first and most important fork in the decision tree is whether it’s ethical or feasible to manipulate the exposure. If you can randomly assign people to smoke, take a hormone therapy, or skip a meal, you’re in experimental-design territory (typically a randomized controlled trial). If you can’t — because doing so would expose participants to known or suspected harm — you’re working with an observational design (Aschengrau & Seage, 2018).

For nearly every example on the Walden suggested list, the answer is no. You cannot ethically randomize people to smoke cigarettes, and you cannot ethically withhold hormone replacement therapy from a control group to study breast cancer risk. That single ethical constraint is what pushes most population health questions toward observational designs by default — not a lack of rigor, but a deliberate methodological choice.

Decision point: ethical to manipulate the exposure?

• Yes → Consider an experimental design (e.g., a randomized controlled trial)
• No → Move to the observational design decision tree below

How Do You Choose the Right Observational Design?

Once you’re in observational territory, two more questions determine whether you need a case-control, cohort, or cross-sectional design: how rare the outcome is, and how long the latency runs between exposure and outcome (Mann, 2003).

Is the outcome rare?

If the health outcome you’re studying is uncommon — most cancers, for instance — a case-control design is usually more efficient. You identify people who already have the outcome (cases) and compare their prior exposure history against people who don’t have it (controls), rather than following a large population forward and waiting for a rare event to occur.

If the outcome is not rare, move to the next question.

Is there long latency between exposure and outcome?

If years or decades typically separate the exposure from the outcome — as with smoking and lung cancer — a cohort design lets you follow exposed and unexposed groups forward over time and observe who develops the outcome and when. This captures the time-ordering that a single snapshot can’t.

If latency is short and the outcome is common, a cross-sectional design — measuring exposure and outcome simultaneously in a single sample — may be the most practical choice, though it comes with real limitations around establishing causation.

Decision point: case-control vs. cohort vs. cross-sectional

• Outcome is rare → Case-control design
• Outcome is common, latency is long → Cohort design
• Outcome is common, latency is short → Cross-sectional design

How Should You Choose Data Collection Methods?

Data collection method should match your study design and your population’s accessibility, not just convenience. A grader isn’t looking for the easiest method — they’re looking for one you can justify.

Common options and where they fit:

• Online surveys — efficient for large, geographically dispersed cohorts, but introduce selection bias if your population doesn’t have reliable internet access
• Existing administrative or clinical records — strong fit for cohort and case-control designs where exposure history needs to be verified rather than self-reported
• Structured interviews — useful for case-control studies where recall accuracy on past exposure matters
• Mailed paper instruments — still relevant for older populations or settings with lower digital access

Whatever you choose, state explicitly why it fits your design and population — that justification is often worth more credit than the choice itself.

What Methodologic Strategies Apply to Each Design?

Each study design has its own selection and measurement logic, and the assignment specifically asks you to explain it.

If you’re running a case-control study:

• Define cases using a clear, consistent diagnostic criterion (incident cases — newly diagnosed — are generally preferred over prevalent cases, which can introduce survival bias) (Centers for Disease Control and Prevention [CDC], 2012)
• Match controls on key confounding variables (age, sex, geography) without over-matching on factors related to the exposure itself
• Watch for selection bias — controls drawn from a hospital population, for example, may differ systematically from the general population

If you’re running a cohort study:

• Define “exposed” and “unexposed” groups with measurable, reproducible criteria at baseline
• Plan for loss to follow-up — attrition over a multi-year cohort can bias results if dropout correlates with exposure or outcome status
• Decide whether you’re running a prospective cohort (following forward from now) or a retrospective cohort (using historical records)

If you’re running an experimental study:

• Explain your randomization method and why it protects against confounding
• Address equipoise — genuine clinical uncertainty about which group benefits, which is what makes randomization ethical in the first place

What Are the Strengths and Limitations of Each Design?

Every study design trades off cost, time, bias risk, and generalizability differently, and naming those tradeoffs explicitly is what separates a strong methods section from a weak one — it’s also what the STROBE reporting guidelines specifically call for when describing observational research (von Elm et al., 2007).

Naming the specific limitation of your chosen design — not just “this study has limitations” — is one of the fastest ways to demonstrate methodological understanding to a grader.

What Ethical Considerations Apply to Epidemiologic Studies?

Ethical review requirements differ meaningfully between observational and experimental designs, and a strong paper addresses the specific risks of the chosen design rather than restating generic research-ethics language. The Declaration of Helsinki remains the foundational reference point for these principles, regardless of design (World Medical Association, 2024).

Key areas to address, regardless of design:

• Informed consent — what participants need to know, and how consent is documented and obtained for your specific data collection method
• Vulnerable populations — if your population includes minors, pregnant individuals, or people with diminished capacity to consent, IRB review requirements intensify
• Data privacy — especially relevant for observational designs using existing clinical or administrative records, where re-identification risk needs explicit mitigation
• Equipoise (experimental designs only) — justifying that genuine uncertainty exists about which group benefits more, which is the ethical foundation for randomization

A common weak spot in student papers is an ethics section that simply states “informed consent will be obtained” without addressing what’s actually at risk for this population and this exposure. Naming the specific risk and how your design mitigates it is what demonstrates real understanding.

Common Pitfalls to Avoid

• Conflating correlation with causation in your write-up, especially when discussing observational findings
• Choosing a design that ignores feasibility constraints described in your own methods section (e.g., proposing a 10-year cohort study with no discussion of funding or follow-up logistics)
• Writing a thin ethics section that restates informed consent without engaging the specific population or exposure
• Skipping the “why not the alternative” reasoning — a strong methods section explains not just why you chose your design, but why the other options were a worse fit

Frequently Asked Questions

{
“@context”: “https://schema.org”,
“@type”: “FAQPage”,
“mainEntity”: [
{
“@type”: “Question”,
“name”: “What is the difference between a cohort study and a case-control study?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “A cohort study follows exposed and unexposed groups forward over time to see who develops an outcome, while a case-control study starts with people who already have the outcome and looks backward at their exposure history. Cohort studies work best for rare exposures with long latency; case-control studies work best for rare outcomes.”
}
},
{
“@type”: “Question”,
“name”: “When should I use a cross-sectional study design?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “Use a cross-sectional design when you need to measure exposure and outcome at a single point in time, typically for common outcomes with short or unclear latency periods. It’s efficient and low-cost but cannot establish that the exposure preceded the outcome.”
}
},
{
“@type”: “Question”,
“name”: “Can I use an experimental design for any population health topic?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “Only when it’s ethical to randomly assign the exposure — experimental designs aren’t appropriate when manipulating the exposure would expose participants to known or suspected harm. Most population health associations involving things like smoking, diet, or hormone exposure are studied observationally for exactly this reason.”
}
},
{
“@type”: “Question”,
“name”: “How do I select cases and controls for a case-control study?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “Define cases using a consistent diagnostic criterion, preferably newly diagnosed (incident) cases rather than long-surviving (prevalent) ones, and match controls on key confounders like age and sex without over-matching on exposure-related factors. Watch for selection bias if your control group is drawn from a non-representative source, such as a single hospital population.”
}
},
{
“@type”: “Question”,
“name”: “What ethical considerations are unique to observational epidemiologic studies?”,
“acceptedAnswer”: {
“@type”: “Answer”,
“text”: “Observational studies using existing records carry data privacy and re-identification risks that experimental studies don’t, since they often draw on clinical or administrative data collected for other purposes. Informed consent procedures also differ depending on whether data is prospectively collected or pulled from historical records.”
}
}
]
}

About the Author

Dan Palmer, MSN, RN, brings direct clinical nursing experience to academic writing support, with a focus on helping graduate nursing students (MSN, DNP, and post-graduate certificate programs) navigate research methodology, evidence-based practice, and epidemiologic study design. His background in both bedside nursing and academic content development informs the practical, application-focused approach used throughout this guide.

Article Update Log

Jun 30, 2026 — Initial publication: comprehensive framework for selecting epidemiologic study designs, covering the observational/experimental decision gate, case-control/cohort/cross-sectional sub-decisions, data collection methods, methodologic strategy, strengths/limitations comparison, and ethical considerations for NURS 8310 Week 4.

References

Aschengrau, A., & Seage, G. R. (2018). Essentials of epidemiology in public health (4th ed.). Jones & Bartlett Learning.

Centers for Disease Control and Prevention. (2012). Principles of epidemiology in public health practice: An introduction to applied epidemiology and biostatistics (3rd ed.). U.S. Department of Health and Human Services. https://www.cdc.gov/csels/dsepd/ss1978/index.html

Curley, A. L. C., Niedz, B. A., & Erikson, A. E. (Eds.). (2025). Population-based nursing: Concepts and competencies for advanced practice (4th ed.). Springer Publishing Company.

Mann, C. J. (2003). Observational research methods. Research design II: Cohort, cross sectional, and case-control studies. Emergency Medicine Journal, 20(1), 54–60. https://doi.org/10.1136/emj.20.1.54

von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. The Lancet, 370(9596), 1453–1457. https://doi.org/10.1016/S0140-6736(07)61602-X

World Medical Association. (2024). WMA Declaration of Helsinki – Ethical principles for medical research involving human participants. https://www.wma.net/policies-post/wma-declaration-of-helsinki/

The post How to Choose an Epidemiologic Study Design (NURS 8310 Week 4 Framework) appeared first on Your Online Resourses Guide.